TSPO and Parkinson disease: This meta-analysis found, in studies using first-generation ligands, elevated TSPO expression in PD participants, relative to HCs, across a range of brain regions, including those characteristically affected in PD such as the substantia nigra, midbrain, caudate, putamen, hippocampus, and cerebral cortex.